SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
846Is the $15MM investment in CTIC new news?tom pope-10/17/2006
845>>Did I miss some major announcement or something???>> Considering Icebrg-10/17/2006
844Did I miss some major announcement or something??? Applications Given Early AntIan@SI-10/17/2006
843I think it is fair to say that people who bought yesterday on the news are pissekenhott-9/19/2006
842Nicely priced to gain admission to the fire sales club.tom pope-9/19/2006
841nvs deadline to opt in is 30 days post approval. Milestones are roughly 40% apprrkrw-9/19/2006
840The Xyotax agreement is not entirely an option (if I got him right at the CC). TIcebrg-9/19/2006
839<i>Corporate jet, anyone ? </i> SEATTLE, Sept. 19 /PRNewswire-Firstnigel bates-9/19/2006
838CTI is so slippery. Not many seem to realize that both xyotax and pixantrone arerkrw-9/19/2006
837CTI, Novartis Enter Xyotax Deal; Option On Pixantrone By Aaron Lorenzo WashingIcebrg-9/19/2006
836Cell Therapeutics:Pixantrone Increases Anti-Tumor Activity 6:06am ET (Dow JoneIan@SI-9/18/2006
835Cell Therapeutics Inc. Announces Worldwide License and Co-Development Agreement Icebrg-9/18/2006
834Cell Therapeutics Says Lawsuit Dismissed Tuesday September 12, 7:27 am ET CeDoc Bones-9/12/2006
833Paclitaxel Poliglumex (XYOTAX(TM)) and Concurrent Radiation Produces Major TumorDoc Bones-8/23/2006
832Cell Therapeutics, Inc. (CTI) Announces Encouraging Pixantrone Phase III InterimIan@SI-8/8/2006
83110qdetective.blogspot.comgcrispin-7/24/2006
830That actually sounds reasonable, unless $170k is too small to motivate Bianco.tom pope-7/15/2006
829Item 1.01. Entry into a Material Definitive Agreement. On July 10, 2006, the CoIcebrg-7/15/2006
828Societe Generale Agrees to Purchase Up to euro 45 Million ($55 million) of CTI CIan@SI-6/21/2006
827They finally found their field of expertise: giving good presentations. :-( SIan@SI-6/20/2006
826Federal Judge Dismisses Shareholder Lawsuit Against Cell Therapeutics, Inc. FridIcebrg-6/9/2006
825If anyone's interested, they plan to talk about this after the market closesIan@SI-6/7/2006
824CTI to File for XYOTAX(TM) Marketing Approval in Europe on Equivalent EffectivenIcebrg-6/7/2006
823Cell Therapeutics' Xyotax holds much promise for few patients 5th June 2006 Icebrg-6/6/2006
822Looks good, now if I could only understand what it means... +++++++++++++++++ Ian@SI-6/4/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News